Prevention and Observation of Surgical Endpoints and Modifiers of Cancer Risk in BRCA 1/2 Mutation Carriers (PROSE-Modifiers Studies) (Collaborative Studies of BRCA 1/2 Mutation Carriers)

NIH Contacts


PROSE Liaison:
Rao L. Divi, Ph.D.

Lead Investigators:

Timothy Rebbeck, Ph.D.
Harvard University

Key to Acronyms Used in Tables

  • EGRP - Epidemiology and Genomics Research Program
  • CDC - Centers for Disease Control and Prevention
  • DCB - Division of Cancer Biology
  • DCEG - Division of Cancer Epidemiology and Genetics
  • NCI - National Cancer Institute
  • NHGRI - National Human Genome Research Institute
  • NIEHS - National Institute of Environmental Health Sciences
  • NIGMS - National Institute of General Medical Sciences
  • NIH - National Institutes of Health
  • OCS - Office of Cancer Survivorship
  • OD - Office of the Director

Return to Top